Exco InTouch set for further growth and expansion following £3.2m investment

2 February 2015

Exco InTouch has announced that it has earmarked capital from the £3.2 million raised from the company’s latest investment round to fund further growth and expansion into healthcare markets in 2015.

The company plans to build on its 2014 achievements which have set it on a course for further growth and new market entry in 2015. Last year saw increased uptake of mobile ePRO, a trend that the company expects to continue this year, and the successful launch into the UK National Health Service of the Me&MyCOPD mHealth Program — an initiative resulting from collaboration between Exco InTouch and AstraZeneca.

Tim Davis, CEO and Founder at Exco InTouch, commented: “We look forward to implementing the next phase of our company’s growth and development strategy with strong confidence, especially as there is such growing demand for our offering across the clinical and healthcare markets. The investment that we continue to attract reflects the success of our company to date and the exciting prospects for the market sectors in which the business operates.”

He continued: “The latest funding will be used for the specific purpose of scaling up and enhancing our platform to meet the increased demand for patient engagement and eCOA whilst also expanding our capabilities as we enter the ‘direct to payer’ market. Exco InTouch has already established itself as a leading provider of mobile healthcare solutions.

"This rapidly growing sector is being driven by the increasing need to demonstrate actual benefits of medical treatments for regulatory and reimbursement purposes. Consequently, our unique offering leads the market in the use of patients’ own mobile devices, reducing the cost for customers and improving user compliance”.

Executive Chairman Dr Neil Rotherham commented, “The application of mobile and digital technologies in the healthcare space is already having a transformational impact. Indeed, we are only at the beginning of a process which will see technology play a critically important role in many aspects of health and wellness.

"Exco InTouch is very well placed to play a leading role in this transition to technology enabled healthcare, having already developed robust solutions that meet exacting regulatory and validation requirements for services being used directly by patients. The latest funding will allow our company to grow both the scale and breadth of its solutions, enabling larger patient populations to be served with richer functional content.

“Our aim it provide services that make a genuine and positive difference to outcomes, whether this is in the broader healthcare sector or within the clinical development environment.”

Source: ExcoIntouch